Unlock instant, AI-driven research and patent intelligence for your innovation.

Bispecific antibodies comprising an antigen-binding site binding to LAG3

A multispecific antibody, bispecific technology for engineered immunoglobulin domains to address immune exhaustion, tumor escape, infection and increased mortality

Pending Publication Date: 2020-09-11
F HOFFMANN LA ROCHE & CO AG
View PDF89 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Activated T cells transiently express PD1, but persistent overexpression of PD1 and its ligand PDL1 promotes immune exhaustion, resulting in persistent viral infection, tumor escape, infection, and increased mortality

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bispecific antibodies comprising an antigen-binding site binding to LAG3
  • Bispecific antibodies comprising an antigen-binding site binding to LAG3
  • Bispecific antibodies comprising an antigen-binding site binding to LAG3

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0241] Generation of a Universal Autonomous Human Heavy Chain Variable Domain (aVH) Library

[0242] Based on the sequence B1ab (a Herceptin derived template) to generate a universal aVH library. In B1ab, four (4) hydrophobic residues that became surface exposed in the absence of the light chain interface were replaced by more hydrophilic residues identified by phage display. These mutations were found to be compatible with structures having a VH domain fold. They increase the hydrophilicity and thus the stability of the scaffold and allow the expression of stable and soluble aVH domains in the absence of light chain partners ( figure 1 A).

[0243] To generate an aVH phage display library based on the B1ab sequence and randomized in the CDR3 region, 2 fragments were assembled by "Splitting by Overlap Extension" (SOE) PCR. Fragment 1 comprises the 5' end of the aVH encoding gene comprising framework 3, while fragment 2 comprises the end of framework 3, framework 4 of the a...

example 2

[0251] Identification of aVH domains containing stabilized disulfide bridges

[0252] To further stabilize the aVH scaffold, the introduction of additional disulfide bridges that constrain the flexibility of the protein chains was tested. Positions that allow disulfide bridge formation when mutated to cysteines were identified by 1) structural modeling, or 2) searching for Ig-like V-type sequences with additional stabilizing disulfide bonds in nature.

[0253] In the first approach, the crystal structure of the molecule with the closest structural homology to the aVH used was identified. (www.pdb.org, entry ID 3B9V). Using a computer algorithm, a Cα / Cα pair with a distance of less than 63 pairs of amino acids. From this 63 pairs, amino acid pairs that had a strong effect on core packing or clearly violated Cβ / Cβ geometry were excluded. Therefore, 8 pairs of different residues were selected.

[0254] In the second approach, manual database screening was performed to ident...

example 3

[0259] Novel library template for generation of a stabilized universal autonomous human heavy chain variable domain (aVH) library

[0260] Based on SEQ ID NO:30 and SEQ ID NO:37, a new aVH library template was designed for generating aVH library with higher stability. The following optional modifications were made in the template sequence: (1) The mutation K94S was introduced. (2) Introduce the mutation L108T, which is a common sequence variant found in antibody J elements. However, the above mutations had no specific effect. image 3 An overview of all library templates is given in .

[0261] Generation of a new universal autonomous human heavy chain variable domain (aVH) library with stabilized disulfide bridge 52a / 71

[0262] To generate new aVH libraries based on additional stabilizing disulfide bridges at positions 52a and 71, four new templates were designed (SEQ ID NO:39, SEQ ID NO:41, SEQ ID NO:43, SEQ ID NO: 45). Three of the four templates had additional sequenc...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to novel antibodies particularly suitable for cancer therapies. The antibodies according to the invention are bispecific or multispecific antibodies and comprise a first antigenbinding site that binds to LAG3. The first antigen binding site is an autonomous VH domain.

Description

technical field [0001] The present invention relates to engineered immunoglobulin domains, more particularly to engineered immunoglobulin heavy chain variable domains with improved stability, and libraries of such immunoglobulin domains. The invention further relates to methods for preparing such immunoglobulin domains, as well as methods of using these immunoglobulin domains. The invention further relates to bispecific or multispecific antibodies comprising an antigen binding site that binds LAG3, polynucleotides encoding such antibodies, and methods of producing such antibodies. Background technique [0002] Single domain antibody fragments may be derived from naturally occurring heavy chain IgG of Camelidae species (referred to as VHH) or the IgNAR of cartilagous sharks (referred to as VNAR). Although single domain antibodies possess several properties that make them interesting candidates for clinical development, non-human single domain antibodies are not suitable for ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K16/28C07K16/46A61K39/395A61P35/02
CPCC07K16/2803C07K16/2818C07K2317/31C07K2317/50C07K2317/526C07K2317/76A61P35/02A61K45/06A61K2039/505
Inventor L·科达里·迪克S·登格尔J·菲舍尔T·霍费L·拉里维雷E·默斯纳S·泽贝尔P·乌玛纳
Owner F HOFFMANN LA ROCHE & CO AG